Methyl 4-hydroxy-7-phenoxyisoquinoline-3-carboxylate, 97.0%, 1g

Methyl 1-(4-chlorophenyl)-3-oxocyclobutane-1-carboxylate, 97%, 2.5g

4'-[(tert-Butyldimethylsilyloxy)methyl]-2,2,2-trifluoroacetophenone>97.0%(GC)5g

2-AMINO-6-METHYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-OL, 95.0%, 250mg

2-CYCLOPROPOXYACETIC ACID, 95%, 1g

2-Chloro-6-trifluoromethylnicotinic acid, 98.0%, 100g

Magnesium fluorosilicate hexahydrate, min. 98%, pure, 500 g, plastic packaging.

(4S,4'S)-2,2'-(1,3-Diphenylpropane-2,2-diyl)bis(4-methyl-4,5-dihydrooxazole), 97%, 250mg

3-(3-methoxyphenyl)-6-(piperazin-1-yl)pyridazine, 95.0%, 2g

1,1'-Biphenyl-2,4'-dimethanol, 95.0%, 250mg

1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydroquinoline-3-carboxylic acid, 95.0%, 100g

Tetraethylphosphonium Tetrafluoroborate>97.0%(T)5g

2-Bromo-4-methyl-5-nitroanisole, 95+%, 250mg